SLC7A11 and cancer: It has been shown that the glutamate/cystine antiporter SLC7A11 can enhance the glucose dependence of renal cancer cell lines and mesothelioma cell lines by exporting glutamate [33], and tryptophan metabolism confer enhanced proliferation and metastasis of cancer cells by regulating immune cell function [34].